Patel Sujal M 4
4 · Nautilus Biotechnology, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Patel Sujal M
DirectorCEO, President, and Secretary10% Owner
Transactions
- Purchase
Common Stock
[F1]2026-03-04$2.61/sh+25,000$65,238→ 10,366,721 total
Holdings
- 5,280,476(indirect: By LLC)
Common Stock
[F2] - 1,814,035(indirect: By Trust)
Common Stock
[F3]
Footnotes (3)
- [F1]Represents the weighted average share price of an aggregate total of 25,000 shares purchased in the price range of $2.48 to $2.6095 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
- [F3]Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
Signature
/s/ Matthew Murphy, as Attorney-in-Fact|2026-03-04